nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP1A2—chronic obstructive pulmonary disease	0.343	1	CbGaD
Zolpidem—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.056	0.136	CbGbCtD
Zolpidem—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0358	0.0868	CbGbCtD
Zolpidem—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0358	0.0868	CbGbCtD
Zolpidem—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0297	0.0721	CbGbCtD
Zolpidem—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0297	0.0721	CbGbCtD
Zolpidem—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0281	0.0681	CbGbCtD
Zolpidem—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0272	0.066	CbGbCtD
Zolpidem—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0272	0.066	CbGbCtD
Zolpidem—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0242	0.0588	CbGbCtD
Zolpidem—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0228	0.0553	CbGbCtD
Zolpidem—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0225	0.0547	CbGbCtD
Zolpidem—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0154	0.0374	CbGbCtD
Zolpidem—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.015	0.0364	CbGbCtD
Zolpidem—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0147	0.0357	CbGbCtD
Zolpidem—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0131	0.0318	CbGbCtD
Zolpidem—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00769	0.0187	CbGbCtD
Zolpidem—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00726	0.0176	CbGbCtD
Zolpidem—Tolmetin—CXCL8—chronic obstructive pulmonary disease	0.00275	0.562	CrCbGaD
Zolpidem—Tolmetin—MPO—chronic obstructive pulmonary disease	0.00214	0.438	CrCbGaD
Zolpidem—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000847	CcSEcCtD
Zolpidem—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000158	0.000847	CcSEcCtD
Zolpidem—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.000847	CcSEcCtD
Zolpidem—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000157	0.000846	CcSEcCtD
Zolpidem—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000157	0.000846	CcSEcCtD
Zolpidem—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000157	0.000846	CcSEcCtD
Zolpidem—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.000843	CcSEcCtD
Zolpidem—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000157	0.000843	CcSEcCtD
Zolpidem—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00084	CcSEcCtD
Zolpidem—Infection—Montelukast—chronic obstructive pulmonary disease	0.000156	0.00084	CcSEcCtD
Zolpidem—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000839	CcSEcCtD
Zolpidem—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000156	0.000839	CcSEcCtD
Zolpidem—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.000839	CcSEcCtD
Zolpidem—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.000836	CcSEcCtD
Zolpidem—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.000832	CcSEcCtD
Zolpidem—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000154	0.000829	CcSEcCtD
Zolpidem—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000153	0.000821	CcSEcCtD
Zolpidem—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000818	CcSEcCtD
Zolpidem—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000815	CcSEcCtD
Zolpidem—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000815	CcSEcCtD
Zolpidem—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00081	CcSEcCtD
Zolpidem—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00015	0.000807	CcSEcCtD
Zolpidem—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.000807	CcSEcCtD
Zolpidem—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000149	0.000803	CcSEcCtD
Zolpidem—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000802	CcSEcCtD
Zolpidem—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000801	CcSEcCtD
Zolpidem—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000799	CcSEcCtD
Zolpidem—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000796	CcSEcCtD
Zolpidem—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.000792	CcSEcCtD
Zolpidem—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.000788	CcSEcCtD
Zolpidem—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.000788	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.000787	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000146	0.000787	CcSEcCtD
Zolpidem—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.000781	CcSEcCtD
Zolpidem—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000145	0.000781	CcSEcCtD
Zolpidem—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000777	CcSEcCtD
Zolpidem—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000144	0.000776	CcSEcCtD
Zolpidem—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000773	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000143	0.00077	CcSEcCtD
Zolpidem—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00077	CcSEcCtD
Zolpidem—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00077	CcSEcCtD
Zolpidem—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000143	0.000767	CcSEcCtD
Zolpidem—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.000767	CcSEcCtD
Zolpidem—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000142	0.000765	CcSEcCtD
Zolpidem—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.000762	CcSEcCtD
Zolpidem—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00076	CcSEcCtD
Zolpidem—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00076	CcSEcCtD
Zolpidem—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000141	0.000759	CcSEcCtD
Zolpidem—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.000757	CcSEcCtD
Zolpidem—Injury—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000752	CcSEcCtD
Zolpidem—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00014	0.000752	CcSEcCtD
Zolpidem—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00014	0.00075	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000139	0.000745	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.000745	CcSEcCtD
Zolpidem—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000744	CcSEcCtD
Zolpidem—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.000744	CcSEcCtD
Zolpidem—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000139	0.000744	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000743	CcSEcCtD
Zolpidem—Pain—Formoterol—chronic obstructive pulmonary disease	0.000137	0.000738	CcSEcCtD
Zolpidem—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.000738	CcSEcCtD
Zolpidem—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000137	0.000738	CcSEcCtD
Zolpidem—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.000738	CcSEcCtD
Zolpidem—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.000737	CcSEcCtD
Zolpidem—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000736	CcSEcCtD
Zolpidem—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000736	CcSEcCtD
Zolpidem—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.000732	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00073	CcSEcCtD
Zolpidem—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000136	0.000729	CcSEcCtD
Zolpidem—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000727	CcSEcCtD
Zolpidem—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000725	CcSEcCtD
Zolpidem—Pain—Montelukast—chronic obstructive pulmonary disease	0.000135	0.000723	CcSEcCtD
Zolpidem—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000723	CcSEcCtD
Zolpidem—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000134	0.000721	CcSEcCtD
Zolpidem—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000719	CcSEcCtD
Zolpidem—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000719	CcSEcCtD
Zolpidem—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000718	CcSEcCtD
Zolpidem—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000717	CcSEcCtD
Zolpidem—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000133	0.000715	CcSEcCtD
Zolpidem—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000133	0.000715	CcSEcCtD
Zolpidem—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000713	CcSEcCtD
Zolpidem—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000132	0.000711	CcSEcCtD
Zolpidem—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.000711	CcSEcCtD
Zolpidem—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000132	0.000711	CcSEcCtD
Zolpidem—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000709	CcSEcCtD
Zolpidem—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000132	0.000707	CcSEcCtD
Zolpidem—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.000706	CcSEcCtD
Zolpidem—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000131	0.000706	CcSEcCtD
Zolpidem—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000705	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.000704	CcSEcCtD
Zolpidem—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.000703	CcSEcCtD
Zolpidem—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000697	CcSEcCtD
Zolpidem—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000697	CcSEcCtD
Zolpidem—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000129	0.000691	CcSEcCtD
Zolpidem—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000691	CcSEcCtD
Zolpidem—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000128	0.000686	CcSEcCtD
Zolpidem—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.000686	CcSEcCtD
Zolpidem—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.000682	CcSEcCtD
Zolpidem—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000127	0.000682	CcSEcCtD
Zolpidem—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000127	0.000682	CcSEcCtD
Zolpidem—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.000682	CcSEcCtD
Zolpidem—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00068	CcSEcCtD
Zolpidem—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.00068	CcSEcCtD
Zolpidem—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000126	0.000674	CcSEcCtD
Zolpidem—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000125	0.000674	CcSEcCtD
Zolpidem—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000125	0.000674	CcSEcCtD
Zolpidem—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000672	CcSEcCtD
Zolpidem—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.000672	CcSEcCtD
Zolpidem—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000125	0.00067	CcSEcCtD
Zolpidem—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000668	CcSEcCtD
Zolpidem—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000668	CcSEcCtD
Zolpidem—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000667	CcSEcCtD
Zolpidem—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.000667	CcSEcCtD
Zolpidem—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00066	CcSEcCtD
Zolpidem—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000655	CcSEcCtD
Zolpidem—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000648	CcSEcCtD
Zolpidem—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000644	CcSEcCtD
Zolpidem—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000644	CcSEcCtD
Zolpidem—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000636	CcSEcCtD
Zolpidem—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000636	CcSEcCtD
Zolpidem—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000118	0.000635	CcSEcCtD
Zolpidem—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000634	CcSEcCtD
Zolpidem—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000623	CcSEcCtD
Zolpidem—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.000619	CcSEcCtD
Zolpidem—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000115	0.000619	CcSEcCtD
Zolpidem—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000114	0.000611	CcSEcCtD
Zolpidem—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000611	CcSEcCtD
Zolpidem—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00061	CcSEcCtD
Zolpidem—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00061	CcSEcCtD
Zolpidem—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000113	0.000607	CcSEcCtD
Zolpidem—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000601	CcSEcCtD
Zolpidem—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000598	CcSEcCtD
Zolpidem—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00011	0.000591	CcSEcCtD
Zolpidem—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.000591	CcSEcCtD
Zolpidem—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000588	CcSEcCtD
Zolpidem—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.000585	CcSEcCtD
Zolpidem—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000582	CcSEcCtD
Zolpidem—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000108	0.000579	CcSEcCtD
Zolpidem—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000577	CcSEcCtD
Zolpidem—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000573	CcSEcCtD
Zolpidem—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000571	CcSEcCtD
Zolpidem—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000571	CcSEcCtD
Zolpidem—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000559	CcSEcCtD
Zolpidem—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.000558	CcSEcCtD
Zolpidem—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00055	CcSEcCtD
Zolpidem—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000549	CcSEcCtD
Zolpidem—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000549	CcSEcCtD
Zolpidem—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000544	CcSEcCtD
Zolpidem—Rash—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000544	CcSEcCtD
Zolpidem—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000544	CcSEcCtD
Zolpidem—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000544	CcSEcCtD
Zolpidem—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000541	CcSEcCtD
Zolpidem—Headache—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000541	CcSEcCtD
Zolpidem—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00054	CcSEcCtD
Zolpidem—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.00054	CcSEcCtD
Zolpidem—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.000539	CcSEcCtD
Zolpidem—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000539	CcSEcCtD
Zolpidem—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.0001	0.000538	CcSEcCtD
Zolpidem—Rash—Montelukast—chronic obstructive pulmonary disease	9.93e-05	0.000533	CcSEcCtD
Zolpidem—Dermatitis—Montelukast—chronic obstructive pulmonary disease	9.92e-05	0.000533	CcSEcCtD
Zolpidem—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	9.9e-05	0.000532	CcSEcCtD
Zolpidem—Depression—Prednisone—chronic obstructive pulmonary disease	9.89e-05	0.000531	CcSEcCtD
Zolpidem—Headache—Montelukast—chronic obstructive pulmonary disease	9.86e-05	0.00053	CcSEcCtD
Zolpidem—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	9.78e-05	0.000525	CcSEcCtD
Zolpidem—Angioedema—Prednisolone—chronic obstructive pulmonary disease	9.75e-05	0.000523	CcSEcCtD
Zolpidem—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	9.72e-05	0.000522	CcSEcCtD
Zolpidem—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	9.72e-05	0.000522	CcSEcCtD
Zolpidem—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.65e-05	0.000518	CcSEcCtD
Zolpidem—Malaise—Prednisolone—chronic obstructive pulmonary disease	9.62e-05	0.000517	CcSEcCtD
Zolpidem—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.58e-05	0.000515	CcSEcCtD
Zolpidem—Rash—Salbutamol—chronic obstructive pulmonary disease	9.57e-05	0.000514	CcSEcCtD
Zolpidem—Syncope—Prednisolone—chronic obstructive pulmonary disease	9.56e-05	0.000514	CcSEcCtD
Zolpidem—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.56e-05	0.000513	CcSEcCtD
Zolpidem—Nausea—Formoterol—chronic obstructive pulmonary disease	9.55e-05	0.000513	CcSEcCtD
Zolpidem—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.55e-05	0.000513	CcSEcCtD
Zolpidem—Headache—Salbutamol—chronic obstructive pulmonary disease	9.51e-05	0.000511	CcSEcCtD
Zolpidem—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	9.37e-05	0.000503	CcSEcCtD
Zolpidem—Nausea—Montelukast—chronic obstructive pulmonary disease	9.35e-05	0.000502	CcSEcCtD
Zolpidem—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.21e-05	0.000495	CcSEcCtD
Zolpidem—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.01e-05	0.000484	CcSEcCtD
Zolpidem—Discomfort—Prednisolone—chronic obstructive pulmonary disease	8.97e-05	0.000482	CcSEcCtD
Zolpidem—Hallucination—Prednisone—chronic obstructive pulmonary disease	8.86e-05	0.000476	CcSEcCtD
Zolpidem—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.00047	CcSEcCtD
Zolpidem—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.7e-05	0.000468	CcSEcCtD
Zolpidem—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.7e-05	0.000468	CcSEcCtD
Zolpidem—Shock—Prednisolone—chronic obstructive pulmonary disease	8.56e-05	0.00046	CcSEcCtD
Zolpidem—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	8.51e-05	0.00159	CbGpPWpGaD
Zolpidem—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.5e-05	0.000456	CcSEcCtD
Zolpidem—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.42e-05	0.000452	CcSEcCtD
Zolpidem—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	8.41e-05	0.00157	CbGpPWpGaD
Zolpidem—Eye disorder—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.000447	CcSEcCtD
Zolpidem—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.26e-05	0.00154	CbGpPWpGaD
Zolpidem—Flushing—Prednisone—chronic obstructive pulmonary disease	8.26e-05	0.000444	CcSEcCtD
Zolpidem—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.24e-05	0.00154	CbGpPWpGaD
Zolpidem—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.17e-05	0.00152	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.17e-05	0.00152	CbGpPWpGaD
Zolpidem—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.13e-05	0.00152	CbGpPWpGaD
Zolpidem—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.08e-05	0.00151	CbGpPWpGaD
Zolpidem—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.06e-05	0.0015	CbGpPWpGaD
Zolpidem—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	7.95e-05	0.000427	CcSEcCtD
Zolpidem—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.92e-05	0.00148	CbGpPWpGaD
Zolpidem—Insomnia—Prednisolone—chronic obstructive pulmonary disease	7.87e-05	0.000423	CcSEcCtD
Zolpidem—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.82e-05	0.00042	CcSEcCtD
Zolpidem—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.82e-05	0.00146	CbGpPWpGaD
Zolpidem—Mental disorder—Prednisone—chronic obstructive pulmonary disease	7.8e-05	0.000419	CcSEcCtD
Zolpidem—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	7.79e-05	0.00145	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.79e-05	0.00145	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	7.78e-05	0.00145	CbGpPWpGaD
Zolpidem—Malnutrition—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.000416	CcSEcCtD
Zolpidem—Erythema—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.000416	CcSEcCtD
Zolpidem—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.68e-05	0.00143	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.58e-05	0.00142	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	7.58e-05	0.00141	CbGpPWpGaD
Zolpidem—Pain—Prednisolone—chronic obstructive pulmonary disease	7.44e-05	0.0004	CcSEcCtD
Zolpidem—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.41e-05	0.00138	CbGpPWpGaD
Zolpidem—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.32e-05	0.00137	CbGpPWpGaD
Zolpidem—Vision blurred—Prednisone—chronic obstructive pulmonary disease	7.3e-05	0.000392	CcSEcCtD
Zolpidem—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.28e-05	0.00136	CbGpPWpGaD
Zolpidem—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.26e-05	0.00136	CbGpPWpGaD
Zolpidem—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.19e-05	0.000386	CcSEcCtD
Zolpidem—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.18e-05	0.00134	CbGpPWpGaD
Zolpidem—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.17e-05	0.000385	CcSEcCtD
Zolpidem—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.16e-05	0.000385	CcSEcCtD
Zolpidem—Agitation—Prednisone—chronic obstructive pulmonary disease	7.12e-05	0.000383	CcSEcCtD
Zolpidem—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.08e-05	0.00038	CcSEcCtD
Zolpidem—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.06e-05	0.00132	CbGpPWpGaD
Zolpidem—Malaise—Prednisone—chronic obstructive pulmonary disease	6.99e-05	0.000375	CcSEcCtD
Zolpidem—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.98e-05	0.0013	CbGpPWpGaD
Zolpidem—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.96e-05	0.000374	CcSEcCtD
Zolpidem—Syncope—Prednisone—chronic obstructive pulmonary disease	6.95e-05	0.000373	CcSEcCtD
Zolpidem—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.92e-05	0.000371	CcSEcCtD
Zolpidem—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.9e-05	0.00129	CbGpPWpGaD
Zolpidem—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.89e-05	0.00129	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.87e-05	0.00128	CbGpPWpGaD
Zolpidem—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.81e-05	0.000366	CcSEcCtD
Zolpidem—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.81e-05	0.00127	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.77e-05	0.00126	CbGpPWpGaD
Zolpidem—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.69e-05	0.000359	CcSEcCtD
Zolpidem—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.69e-05	0.00125	CbGpPWpGaD
Zolpidem—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.68e-05	0.00125	CbGpPWpGaD
Zolpidem—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.66e-05	0.00124	CbGpPWpGaD
Zolpidem—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.62e-05	0.00124	CbGpPWpGaD
Zolpidem—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.000354	CcSEcCtD
Zolpidem—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.000354	CcSEcCtD
Zolpidem—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.58e-05	0.000353	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.000352	CcSEcCtD
Zolpidem—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.52e-05	0.00035	CcSEcCtD
Zolpidem—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.41e-05	0.000344	CcSEcCtD
Zolpidem—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.39e-05	0.00119	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	6.33e-05	0.00118	CbGpPWpGaD
Zolpidem—Oedema—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.00034	CcSEcCtD
Zolpidem—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.00034	CcSEcCtD
Zolpidem—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.32e-05	0.00118	CbGpPWpGaD
Zolpidem—Infection—Prednisone—chronic obstructive pulmonary disease	6.28e-05	0.000338	CcSEcCtD
Zolpidem—Shock—Prednisone—chronic obstructive pulmonary disease	6.22e-05	0.000334	CcSEcCtD
Zolpidem—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.2e-05	0.000333	CcSEcCtD
Zolpidem—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.17e-05	0.000332	CcSEcCtD
Zolpidem—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.14e-05	0.00033	CcSEcCtD
Zolpidem—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.000328	CcSEcCtD
Zolpidem—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.03e-05	0.000324	CcSEcCtD
Zolpidem—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.01e-05	0.00112	CbGpPWpGaD
Zolpidem—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	5.9e-05	0.0011	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.88e-05	0.0011	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.83e-05	0.00109	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.81e-05	0.00108	CbGpPWpGaD
Zolpidem—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.00031	CcSEcCtD
Zolpidem—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.76e-05	0.00107	CbGpPWpGaD
Zolpidem—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.76e-05	0.000309	CcSEcCtD
Zolpidem—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.73e-05	0.00107	CbGpPWpGaD
Zolpidem—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.72e-05	0.000307	CcSEcCtD
Zolpidem—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.68e-05	0.000305	CcSEcCtD
Zolpidem—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.66e-05	0.00106	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.65e-05	0.00105	CbGpPWpGaD
Zolpidem—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.57e-05	0.000299	CcSEcCtD
Zolpidem—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	5.55e-05	0.00104	CbGpPWpGaD
Zolpidem—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000295	CcSEcCtD
Zolpidem—Rash—Prednisolone—chronic obstructive pulmonary disease	5.49e-05	0.000295	CcSEcCtD
Zolpidem—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.48e-05	0.000295	CcSEcCtD
Zolpidem—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.000293	CcSEcCtD
Zolpidem—Headache—Prednisolone—chronic obstructive pulmonary disease	5.45e-05	0.000293	CcSEcCtD
Zolpidem—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.42e-05	0.00101	CbGpPWpGaD
Zolpidem—Constipation—Prednisone—chronic obstructive pulmonary disease	5.41e-05	0.000291	CcSEcCtD
Zolpidem—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.39e-05	0.00101	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	5.38e-05	0.001	CbGpPWpGaD
Zolpidem—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.32e-05	0.000992	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.31e-05	0.000991	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.26e-05	0.000983	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.24e-05	0.000977	CbGpPWpGaD
Zolpidem—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.21e-05	0.00028	CcSEcCtD
Zolpidem—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.19e-05	0.000969	CbGpPWpGaD
Zolpidem—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.17e-05	0.000278	CcSEcCtD
Zolpidem—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.17e-05	0.000278	CcSEcCtD
Zolpidem—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.00027	CcSEcCtD
Zolpidem—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5e-05	0.000269	CcSEcCtD
Zolpidem—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5e-05	0.000269	CcSEcCtD
Zolpidem—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.99e-05	0.000931	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.98e-05	0.000929	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.92e-05	0.000919	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.92e-05	0.000918	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.88e-05	0.000912	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.84e-05	0.000904	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.82e-05	0.000899	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.78e-05	0.000892	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.77e-05	0.000891	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.68e-05	0.000874	CbGpPWpGaD
Zolpidem—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.00025	CcSEcCtD
Zolpidem—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.59e-05	0.000857	CbGpPWpGaD
Zolpidem—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.54e-05	0.000244	CcSEcCtD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.49e-05	0.000838	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.49e-05	0.000838	CbGpPWpGaD
Zolpidem—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.48e-05	0.00024	CcSEcCtD
Zolpidem—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.43e-05	0.000827	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.37e-05	0.000815	CbGpPWpGaD
Zolpidem—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.37e-05	0.000815	CbGpPWpGaD
Zolpidem—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.33e-05	0.000232	CcSEcCtD
Zolpidem—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.18e-05	0.000225	CcSEcCtD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.09e-05	0.000764	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.07e-05	0.00076	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.07e-05	0.00076	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.04e-05	0.000755	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.04e-05	0.000754	CbGpPWpGaD
Zolpidem—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.02e-05	0.000216	CcSEcCtD
Zolpidem—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.02e-05	0.00075	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	4.01e-05	0.000749	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.01e-05	0.000749	CbGpPWpGaD
Zolpidem—Rash—Prednisone—chronic obstructive pulmonary disease	3.99e-05	0.000214	CcSEcCtD
Zolpidem—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.98e-05	0.000214	CcSEcCtD
Zolpidem—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.98e-05	0.000743	CbGpPWpGaD
Zolpidem—Headache—Prednisone—chronic obstructive pulmonary disease	3.96e-05	0.000213	CcSEcCtD
Zolpidem—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.88e-05	0.000725	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.86e-05	0.00072	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.84e-05	0.000717	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.84e-05	0.000716	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.8e-05	0.00071	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.8e-05	0.00071	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.8e-05	0.000709	CbGpPWpGaD
Zolpidem—Nausea—Prednisone—chronic obstructive pulmonary disease	3.76e-05	0.000202	CcSEcCtD
Zolpidem—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.74e-05	0.000699	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.71e-05	0.000693	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.71e-05	0.000693	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.71e-05	0.000692	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.7e-05	0.000691	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.69e-05	0.000689	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.68e-05	0.000687	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.66e-05	0.000683	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.64e-05	0.000679	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.64e-05	0.000679	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.64e-05	0.000679	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.62e-05	0.000675	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	3.58e-05	0.000668	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.57e-05	0.000666	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.55e-05	0.000663	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.55e-05	0.000662	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.54e-05	0.00066	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.52e-05	0.000657	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.5e-05	0.000653	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.5e-05	0.000653	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.47e-05	0.000648	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	3.47e-05	0.000647	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.47e-05	0.000647	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.47e-05	0.000647	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.45e-05	0.000644	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.4e-05	0.000635	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.33e-05	0.000621	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.26e-05	0.000608	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.22e-05	0.000602	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.19e-05	0.000596	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.17e-05	0.000592	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.15e-05	0.000588	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.13e-05	0.000584	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.1e-05	0.000579	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.1e-05	0.000579	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.01e-05	0.000561	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.96e-05	0.000553	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.85e-05	0.000533	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.83e-05	0.000528	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.66e-05	0.000497	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.66e-05	0.000496	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.63e-05	0.000491	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.63e-05	0.00049	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.59e-05	0.000483	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.57e-05	0.00048	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.45e-05	0.000457	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.42e-05	0.000451	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.41e-05	0.000451	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.41e-05	0.000449	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.33e-05	0.000435	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.32e-05	0.000433	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.29e-05	0.000427	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.22e-05	0.000415	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.21e-05	0.000413	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.19e-05	0.000408	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.17e-05	0.000405	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.13e-05	0.000398	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.06e-05	0.000384	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.04e-05	0.000381	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.02e-05	0.000377	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2e-05	0.000373	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.96e-05	0.000365	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.93e-05	0.000361	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.9e-05	0.000354	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.89e-05	0.000353	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.87e-05	0.00035	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.87e-05	0.00035	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.87e-05	0.000348	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.86e-05	0.000348	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.86e-05	0.000347	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.86e-05	0.000347	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.84e-05	0.000343	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.82e-05	0.00034	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.76e-05	0.000329	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.75e-05	0.000326	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.72e-05	0.000322	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.71e-05	0.000319	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.71e-05	0.000319	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.7e-05	0.000316	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.62e-05	0.000303	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.6e-05	0.000299	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.57e-05	0.000294	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.56e-05	0.000291	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.48e-05	0.000277	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.45e-05	0.00027	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.41e-05	0.000264	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.4e-05	0.000261	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.36e-05	0.000253	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.35e-05	0.000252	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.34e-05	0.000249	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.31e-05	0.000245	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.3e-05	0.000242	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.27e-05	0.000238	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.25e-05	0.000232	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.24e-05	0.000231	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.21e-05	0.000225	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.2e-05	0.000224	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.18e-05	0.00022	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.17e-05	0.000219	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000215	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.14e-05	0.000214	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.12e-05	0.000209	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.000204	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000202	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.01e-05	0.000188	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1e-05	0.000188	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.96e-06	0.000186	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.93e-06	0.000185	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.86e-06	0.000184	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.85e-06	0.000184	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.8e-06	0.000183	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.66e-06	0.00018	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.18e-06	0.000171	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.08e-06	0.000169	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.06e-06	0.000169	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	9e-06	0.000168	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	8.99e-06	0.000168	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.53e-06	0.000159	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.51e-06	0.000159	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.42e-06	0.000157	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.35e-06	0.000156	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.28e-06	0.000155	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	8.02e-06	0.00015	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.85e-06	0.000146	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	7.78e-06	0.000145	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.68e-06	0.000143	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	7.68e-06	0.000143	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.57e-06	0.000141	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.47e-06	0.000139	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.44e-06	0.000139	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.97e-06	0.00013	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.96e-06	0.00013	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.91e-06	0.000129	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.87e-06	0.000128	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.81e-06	0.000127	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.6e-06	0.000123	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.57e-06	0.000123	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.49e-06	0.000121	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.4e-06	0.000119	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.35e-06	0.000118	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.07e-06	0.000113	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.02e-06	0.000112	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.93e-06	0.000111	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.9e-06	0.00011	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.82e-06	0.000109	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	5.8e-06	0.000108	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.55e-06	0.000104	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.46e-06	0.000102	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.42e-06	0.000101	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.14e-06	9.6e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.55e-06	8.5e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.49e-06	8.38e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.48e-06	8.37e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.29e-06	8.01e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.19e-06	7.81e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.12e-06	7.7e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.09e-06	7.63e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.97e-06	7.41e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.95e-06	7.36e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.91e-06	7.3e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.49e-06	6.52e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.34e-06	6.24e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.7e-06	5.03e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.58e-06	4.82e-05	CbGpPWpGaD
